These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12867907)

  • 41. A comparison of obstetrical outcomes with labor induction agents used at term.
    Aghideh FK; Mullin PM; Ingles S; Ouzounian JG; Opper N; Wilson ML; Miller DA; Lee RH
    J Matern Fetal Neonatal Med; 2014 Apr; 27(6):592-6. PubMed ID: 23919802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaginal misoprostol for cervical ripening and labour induction in late pregnancy.
    Hofmeyr GJ; Gulmezoglu AM
    Birth; 1999 Dec; 26(4):264. PubMed ID: 10655835
    [No Abstract]   [Full Text] [Related]  

  • 43. A randomized controlled trial comparing vaginal misoprostol versus Foley catheter plus oxytocin for labor induction.
    Moraes Filho OB; Albuquerque RM; Cecatti JG
    Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1045-52. PubMed ID: 20636243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Misoprostol off label essential for women's health].
    Danielsson KG
    Lakartidningen; 2013 Nov 13-19; 110(46):2045-6. PubMed ID: 24380157
    [No Abstract]   [Full Text] [Related]  

  • 45. Effectiveness and safety of a new vaginal misoprostol product specifically labeled for cervical ripening and labor induction.
    Cecatti JG; Tedesco RP; Pires HM; Calderon IM; Faúndes A
    Acta Obstet Gynecol Scand; 2006; 85(6):706-11. PubMed ID: 16752263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of labour with misoprostol.
    Hofmeyr GJ
    Curr Opin Obstet Gynecol; 2001 Dec; 13(6):577-81. PubMed ID: 11707660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Women's Experiences with and Preference for Induction of Labor with Oral Misoprostol or Foley Catheter at Term.
    Ten Eikelder ML; van de Meent MM; Mast K; Rengerink KO; Jozwiak M; de Graaf IM; Scholtenhuis MA; Roumen FJ; Porath MM; van Loon AJ; van den Akker ES; Rijnders RJ; Feitsma AH; Adriaanse AH; Muller MA; de Leeuw JW; Visser H; Woiski MD; Weerd SR; van Unnik GA; Pernet PJ; Versendaal H; Mol BW; Bloemenkamp KW
    Am J Perinatol; 2017 Jan; 34(2):138-146. PubMed ID: 27341122
    [No Abstract]   [Full Text] [Related]  

  • 48. Labor induction with misoprostol.
    Wing DA
    Am J Obstet Gynecol; 1999 Aug; 181(2):339-45. PubMed ID: 10454679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Labor induction with prostaglandin E1 misoprostol compared with dinoprostone vaginal insert: a randomized trial.
    Sanchez-Ramos L; Peterson DE; Delke I; Gaudier FL; Kaunitz AM
    Obstet Gynecol; 1998 Mar; 91(3):401-5. PubMed ID: 9491868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized comparison between intravaginal misoprostol and prostaglandin E2 for labor induction.
    Sifakis S; Angelakis E; Avgoustinakis E; Fragouli Y; Mantas N; Koukoura O; Vardaki E; Koumantakis E
    Arch Gynecol Obstet; 2007 Apr; 275(4):263-7. PubMed ID: 17028904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A tale of two births: the healing power of VBAC.
    Trout KK
    Midwifery Today Int Midwife; 2010-2011 Winter; (96):26-8, 67. PubMed ID: 21322446
    [No Abstract]   [Full Text] [Related]  

  • 52. Misoprostol and pregnancy.
    Goldberg AB; Greenberg MB; Darney PD
    N Engl J Med; 2001 Jan; 344(1):38-47. PubMed ID: 11136959
    [No Abstract]   [Full Text] [Related]  

  • 53. Resources for evidence-based practice, March/April 2003.
    J Midwifery Womens Health; 2003; 48(2):149-52. PubMed ID: 12686949
    [No Abstract]   [Full Text] [Related]  

  • 54. Misoprostol for cervical ripening and labor induction.
    Votipka JR
    J Fam Pract; 1997 Jul; 45(1):20. PubMed ID: 9228905
    [No Abstract]   [Full Text] [Related]  

  • 55. Misoprostol (Cytotec): a new method of inducing labor.
    Enoch J
    Midwifery Today Int Midwife; 1999; (49):22-30. PubMed ID: 10488311
    [No Abstract]   [Full Text] [Related]  

  • 56. A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction.
    Wing DA; Ham D; Paul RH
    Am J Obstet Gynecol; 1999 May; 180(5):1155-60. PubMed ID: 10329871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. "Pit to distress": is this an evidence-based strategy?
    Tillett J
    J Perinat Neonatal Nurs; 2011; 25(4):302-4. PubMed ID: 22071610
    [No Abstract]   [Full Text] [Related]  

  • 58. Induction of labor with vaginal misoprostol plus oxytocin versus oxytocin alone.
    Balci O; Mahmoud AS; Ozdemir S; Acar A
    Int J Gynaecol Obstet; 2010 Jul; 110(1):64-7. PubMed ID: 20347088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Misoprostol for induction of labor.
    Gonzalez Pena JC
    Am J Obstet Gynecol; 1996 Feb; 174(2):797. PubMed ID: 8623826
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of the safety and efficacy of intravaginal misoprostol (prostaglandin E1) with those of dinoprostone (prostaglandin E2) for cervical ripening and induction of labor in a community hospital.
    Blanchette HA; Nayak S; Erasmus S
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 1):1551-9. PubMed ID: 10368503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.